ZENAS BIOPHARMA
(NASDAQ: ZBIO)

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

20.560

-0.675 (-3.18%)
Range 20.380 - 21.460   (5.30%)
Open 21.300
Previous Close 21.235
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 23,903
Value -
Remark
Delayed prices. Updated at 01 Nov 2024 22:35.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis